Page last updated: 2024-08-24

cidofovir anhydrous and Hodgkin Disease

cidofovir anhydrous has been researched along with Hodgkin Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldelli, F; De Socio, GV; Minga, P; Rosignoli, D; Simonetti, S; Tomassini, GM1
Abdelhalim, A; Almyroudis, NG; Battiwalla, M; Becker, J; Elefante, A; McCarthy, A; McCarthy, PL; Paplham, P; Segal, BH; Smith, P1

Other Studies

2 other study(ies) available for cidofovir anhydrous and Hodgkin Disease

ArticleYear
Topical cidofovir for severe warts in a patient affected by AIDS and Hodgkin's lymphoma.
    International journal of STD & AIDS, 2008, Volume: 19, Issue:10

    Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Foot; Hand; HIV Infections; Hodgkin Disease; Human papillomavirus 16; Humans; Lymphoma, AIDS-Related; Male; Organophosphonates; Papillomaviridae; Treatment Outcome; Warts

2008
Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:1

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Encephalitis, Viral; Fatal Outcome; Ganciclovir; Hodgkin Disease; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Organophosphonates; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Renal Insufficiency; Secondary Prevention; Treatment Failure; Virus Activation

2007